Monte Rosa Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Monte Rosa Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Monte Rosa Therapeutics Inc
Rating: 1.93908325
Author: Trendlyne DVM scores

about

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degra...

21.98 -1.06 (-4.60%)

433.50% Gain from 52W Low

1.6M

XNAS Volume

XNAS 13 Jul, 2026 4:16 PM (EDT)

Not Eligible

Expensive Valuation

10.8 / 100

Technically Moderately Bullish

66.7 / 100

1Yr Price target upside is 51%

6 analysts

Monte Rosa Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Monte Rosa Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Monte Rosa Therapeutics Inc is a clinical-stage biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degra...

433.50% Gain from 52W Low

SWOT Analysis

Monte Rosa Therapeutics Inc Live Price Chart

Monte Rosa Therapeutics Inc Live Price Chart